Time-to-antibiotic administration as a quality of care measure in children with febrile neutropenia: A survey of pediatric oncology centers

被引:33
|
作者
McCavit, Timothy L. [1 ,2 ]
Winick, Naomi [1 ,2 ]
机构
[1] Univ Texas SW Med Ctr Dallas, Div Hematol Oncol, Dallas, TX 75390 USA
[2] Childrens Med Ctr, Ctr Canc & Blood Disorders, Dallas, TX 75235 USA
关键词
febrile neutropenia; prevalence; quality of care; time-to-antibiotics; MORTALITY; DELAY; MENINGITIS; OUTCOMES; THERAPY;
D O I
10.1002/pbc.23148
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Time-to-antibiotic administration (TTA) has been suggested as a quality-of-care (QOC) measure for pediatric oncology patients with febrile neutropenia (FN). Unknown, however, is to what extent pediatric oncology centers utilize TTA. Therefore, we designed and administered an electronic survey (68% response rate) of programs in the Children's Oncology Group to assess TTA utilization. Nearly half of respondents track TTA. Most reported using a benchmark of less than 60 min from arrival. TTA is a commonly used QOC measure for pediatric FN despite an absence of studies establishing its validity and a lack of data supporting its impact on outcomes of FN. Pediatr Blood Cancer 2012; 58: 303305. (C) 2011 Wiley Periodicals, Inc.
引用
收藏
页码:303 / 305
页数:3
相关论文
共 50 条
  • [31] Outpatient versus inpatient IV antibiotic management for pediatric oncology patients with low risk febrile neutropenia: A randomised trial
    Orme, Lisa M.
    Babl, Franz E.
    Barnes, Chris
    Barnett, Peter
    Donath, Susan
    Ashley, David M.
    PEDIATRIC BLOOD & CANCER, 2014, 61 (08) : 1427 - 1433
  • [32] Impact of time to antibiotic on hospital stay, intensive care unit admission, and mortality in febrile neutropenia
    Daniels, Lisa M.
    Durani, Urshila
    Barreto, Jason N.
    O'Horo, John C.
    Siddiqui, Mustaqeem A.
    Park, John G.
    Tosh, Pritish K.
    SUPPORTIVE CARE IN CANCER, 2019, 27 (11) : 4171 - 4177
  • [33] Impact of time to antibiotic on hospital stay, intensive care unit admission, and mortality in febrile neutropenia
    Lisa M. Daniels
    Urshila Durani
    Jason N. Barreto
    John C. O’Horo
    Mustaqeem A. Siddiqui
    John G. Park
    Pritish K. Tosh
    Supportive Care in Cancer, 2019, 27 : 4171 - 4177
  • [34] Survey of practices for the clinical management of febrile neutropenia in children in hematology-oncology units in Latin America
    Melgar, Mario A.
    Homsi, Maysam R.
    Happ, Brooke
    Su, Yin
    Tang, Li
    Gonzalez, Miriam L.
    Caniza, Miguela A.
    SUPPORTIVE CARE IN CANCER, 2021, 29 (12) : 7903 - 7911
  • [35] Survey of practices for the clinical management of febrile neutropenia in children in hematology-oncology units in Latin America
    Mario A. Melgar
    Maysam R. Homsi
    Brooke Happ
    Yin Su
    Li Tang
    Miriam L. Gonzalez
    Miguela A. Caniza
    Supportive Care in Cancer, 2021, 29 : 7903 - 7911
  • [36] Absolute Monocyte Count as Early and Safe Marker for Antibiotic Cessation in Febrile Neutropenia Without Etiology in Pediatric Oncology Patients
    Alali, Muayad
    Prather, Cassandra
    Danziger-Isakov, Lara A.
    Kussin, Michelle L.
    Khalifeh, Malak
    Al Othman, Nashwan
    Bartlett, Allison H.
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2023, 45 (06) : E702 - E709
  • [37] Outpatient versus inpatient IV antibiotic management for pediatric oncology patients with low risk febrile neutropenia: A randomised trial
    Mathew, Jospeh L.
    INDIAN PEDIATRICS, 2014, 51 (08) : 659 - 660
  • [38] Outpatient versus inpatient IV antibiotic management for pediatric oncology patients with low risk febrile neutropenia: A randomised trial
    Jospeh L. Mathew
    Ramandeep Singh Arora
    Janani Sankar
    Indian Pediatrics, 2014, 51 : 659 - 661
  • [39] Using the Model for Improvement to Decrease Time to Antibiotic Administration Among Pediatric Oncology Patients with Fever and Neutropenia in Two Emergency Departments in Mexico
    Escobedo-Melendez, G.
    Echavarria, M.
    Guerrero, K.
    Tostado, E.
    Gallegos-Castorena, S.
    Araujo, M.
    Barriga-Marin, A.
    Salas, K.
    Navarro-Diaz, D.
    Rodriguez-Gonzalez, G.
    Pena, L.
    Acuna-Chavez, N.
    Cortes-Valladolid, D.
    Castillon, Z.
    Danheli, R. F.
    Gonzalez, M.
    Echeandia, N.
    Caniza, M.
    Friedrich, P.
    PEDIATRIC BLOOD & CANCER, 2019, 66 : S13 - S14
  • [40] Hospital Based Initiative to Minimize the Time to Antibiotic Administration in Febrile Immunocompromised Pediatric Patients
    Linga, Vijay
    Ghawi, Husam
    Bhatt, Parth
    Rodriques, Brooke
    Turner, Curtis
    Bhaskaran, Smita
    PEDIATRIC BLOOD & CANCER, 2017, 64 : S63 - S63